Ceru S, Pancera P, Sansone S, Sfondrini G, Codella O, De Sandre G, Lechi A, Lunardi C
Institute of Internal Medicine, Policlinico Borgo Roma, University of Verona, Italy.
Clin Exp Rheumatol. 1997 Jul-Aug;15(4):381-5.
To evaluate the effects of iloprost infusion on the microcirculation in patients suffering from severe Raynaud's phenomenon secondary to systemic sclerosis.
Eight patients received a 7-hour infusion of iloprost for five consecutive days and then for one day 3 months later. The effects on vascular distensibility were evaluated by piezoelectric plethysmography before and after the treatment and at 2, 4 and 6 weeks.
The beneficial effects on the peripheral microcirculation were statistically significant after five days of infusion (distensibility index: 0.18 +/- 0.01 vs 0.23 +/- 0.01, p < 0.002) and lasted for less than four weeks, whereas no difference (0.22 +/- 0.04 vs 0.24 +/- 0.02, p: ns) was seen after one day of treatment. One patient suffered from typical angina pectoris with electrocardiographic changes of the ST wave detected during the infusion.
Our results show that a five-day infusion of iloprost has an effect which lasts from two to four weeks; after four weeks the distensibility index returned to the baseline value. The one-day infusion had no effect on the vascular bed, studied by the piezoelectric pletysmographic method. Treatment with five consecutive days of infusion every four weeks is an impracticable scheme to adopt, however. We have therefore instituted a treatment schedule of a single daily infusion every four weeks with the aim of maintaining the effects induced by the initial five-day infusion. The preliminary results obtained with this schedule are reported.
评估伊洛前列素输注对继发于系统性硬化症的严重雷诺现象患者微循环的影响。
8例患者连续5天接受7小时的伊洛前列素输注,3个月后再进行1天的输注。在治疗前、治疗后以及治疗后2周、4周和6周,通过压电体积描记法评估对血管扩张性的影响。
输注5天后对外周微循环的有益影响具有统计学意义(扩张性指数:0.18±0.01对0.23±0.01,p<0.002),且持续时间不到4周,而治疗1天后未见差异(0.22±0.04对0.24±0.02,p:无统计学意义)。1例患者在输注期间出现典型心绞痛,伴有ST段心电图改变。
我们的结果表明,5天的伊洛前列素输注具有持续2至4周的效果;4周后扩张性指数恢复到基线值。通过压电体积描记法研究发现,1天的输注对血管床无影响。然而,每4周连续5天输注的治疗方案难以实施。因此,我们制定了每4周每日单次输注的治疗方案,旨在维持最初5天输注所诱导的效果。报告了该方案获得的初步结果。